Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Unrealistic Optimism Bias01:30

Unrealistic Optimism Bias

Unrealistic optimism bias is the tendency to overestimate the likelihood of positive outcomes. This cognitive bias makes individuals believe they are less likely to experience failures, setbacks, or risks and more likely to succeed than others. For example, people may assume they are less prone to health issues, accidents, or financial struggles than their peers, even when they share similar risk factors.One key component of this bias is the above-average effect, where individuals perceive...
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's proficiency in drug...
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Modeling and Similitude01:12

Modeling and Similitude

Scaled modeling is a fundamental technique in engineering, enabling the study of large and complex systems by creating smaller, manageable replicas that recreate critical characteristics of the original. In hydrology and civil infrastructure, for example, scaled models of dams help analyze water flow, turbulence, and pressure. This method allows for accurate predictions of real-world behavior within a controlled environment, significantly reducing the cost and time involved in full-scale...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and opportunities in computational studies for lipid nanoparticle development.

npj drug discovery·2026
Same author

Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.

Journal of medicinal chemistry·2020
Same author

Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.

Journal of medicinal chemistry·2020
Same author

The evolution of library design: crafting smart compound collections for phenotypic screens.

Drug discovery today. Technologies·2017
Same author

POSIT: Flexible Shape-Guided Docking For Pose Prediction.

Journal of chemical information and modeling·2015
Same author

Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation.

Bioscience reports·2014
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Healthy skepticism: assessing realistic model performance.

Scott P Brown1, Steven W Muchmore, Philip J Hajduk

  • 1Structural Biology, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA.

Drug Discovery Today
|April 3, 2009
PubMed
Summary
This summary is machine-generated.

Computational models in drug discovery show promise but often underperform due to data errors. Addressing assay and prediction reliability is key to improving their impact on pharmaceutical research.

Related Experiment Videos

Last Updated: Jun 24, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Pharmaceutical research

Background:

  • Computational models are crucial in modern drug discovery.
  • Their real-world impact on productivity is often limited.
  • Underlying data quality and model integration pose significant challenges.

Purpose of the Study:

  • To analyze the impact of assay and prediction errors on computational model quality.
  • To explore scenarios where these models can significantly influence drug discovery.
  • To identify strategies for enhancing the reliability and application of computational models.

Main Methods:

  • Review of existing literature on computational models in drug discovery.
  • Analysis of the effects of assay errors on predictive model performance.
  • Examination of prediction errors and their influence on model reliability.
  • Case study analysis of model integration in medicinal chemistry workflows.

Main Results:

  • Assay and prediction errors significantly degrade computational model reliability.
  • Neglected data quality issues often lead to overestimated model performance.
  • Successful integration into medicinal chemistry campaigns is hindered by practical challenges.

Conclusions:

  • Improving data quality and understanding error sources are essential for effective computational drug discovery.
  • Computational models can significantly impact drug discovery when their limitations are acknowledged and addressed.
  • Future research should focus on robust error assessment and seamless model integration.